Find Academic Supervisors

Laura PowerView profile

Associate Clinical Professor

• Public Health Practice
• Infectious Diseases
• Public Health Workforce Development
• +3 more

Laura Power serves as Clinical Associate Professor in Epidemiology at the University of Michigan School of Public Health and Infectious Diseases (Internal Medicine), directing the Office of Public Health Practice. Her work bridges medical practice and public health through experiential learning, workforce development, and infectious disease epidemiology initiatives. Her educational background includes: BA from Albion College (1998) MD from Wayne State University School of Medicine (2002) MPH from University of Michigan School of Public Health (2015) Her research centers on public health practice systems, workforce capacity building, and infectious disease prevention. Recent projects include HRSA-funded Region V Public Health Training Center and Preventive Medicine Residency Program, focusing on applied epidemiology and outbreak response training. Her scholarly work demonstrates consistent emphasis on antimicrobial resistance, diagnostic accuracy, and translational public health practice. Her 15 most recent publications reveal strong focus on infectious disease epidemiology (73%), public health practice systems (60%), and antimicrobial resistance (47%), with growing emphasis on workforce development and outbreak response since 2016. Key trends include methodological innovation in surveillance systems and practical interventions for healthcare-associated infections. Dr. Power actively mentors students through the Public Health Action Support Team (PHAST) and Public Health in Action courses, connecting academic training with community practice. Her HRSA-funded programs support over 200 public health practitioners annually through the Region V Leadership Institute and residency training. She leads the Office of Public Health Practice, Region V Public Health Training Center, and Public Health Prepared program—fostering partnerships between academic, governmental, and community health organizations to enhance outbreak response capacity.

Anabel RodriguezView profile

Assistant Professor

• Occupational Health and Safety
• Agricultural Workers Health
• Immigrant and Migrant Health
• +6 more

Dr. Anabel Rodriguez is an Assistant Professor in the Department of Environmental and Occupational Health at Texas A&M University, dedicated to improving occupational health and safety among agricultural working populations. Her research focuses on Spanish and Indigenous-speaking immigrant and migrant farmworkers in rural Texas and U.S.-Mexico border regions, addressing tuberculosis prevention, vaccine access barriers, and health disparities in medically underserved 'health deserts'. Education: PhD, University of Texas Health Science Center at Houston, School of Public Health MPH, University of Texas Health Science Center at Houston, School of Public Health BS, Saint Edward's University Research Focus: Dr. Rodriguez investigates occupational epidemiology and social determinants of health in precarious agricultural employment, with emphasis on infectious disease prevention (tuberculosis, influenza, brucellosis) and vaccine equity. Her work integrates Total Worker Health® approaches to address mental health barriers, diabetes management, and safety climate in dairy operations through community-based interventions. Publication Trends: Recent articles (2023-2025) reveal three dominant themes: 1) Safety leadership training for dairy supervisors using mobile technology, 2) Infection control program development for rural healthcare workers, and 3) Analysis of social-structural barriers affecting migrant shrimpers and farmworkers. Her research consistently centers on hard-to-reach populations in Texas border communities using culturally tailored methods. Professional Context: As the daughter of Mexican immigrant seasonal farmworkers from the Rio Grande Valley, Dr. Rodriguez brings lived experience to her work. She develops training programs for occupational safety and infectious disease prevention while teaching courses in Occupational Epidemiology and Immigrant Working Populations. Her contact: anabelr@tamu.edu | 979.436.9329 | 212 Adriance Lab Rd., College Station, TX.

• HIV/AIDS Epidemiology
• Infectious Disease Prevention
• Research Ethics
• +6 more

Kaveh Khoshnood is an Associate Professor of Epidemiology (Microbial Diseases) at the Yale School of Public Health, where he serves as Director of Undergraduate Studies and Faculty Director for the Humanitarian Research Lab. He is Program Co-Director of the Global Health Ethics Program at the Yale Institute for Global Health and an executive committee member at the Yale Council on Middle East Studies. Dr. Khoshnood's academic affiliations span multiple departments and organizations including: Epidemiology of Microbial Diseases (Primary Appointment) School of Nursing (Secondary Appointment) African Studies Center for Interdisciplinary Research on AIDS Climate Change and Health Formative Childhood and Peace Building GEOHealth-MENA program Global Health Studies Yale Center for Asylum Medicine Yale Institute for Global Health Trained as an infectious disease epidemiologist with over three decades of experience, Dr. Khoshnood specializes in HIV prevention research among people who use drugs and other at-risk populations. His research interests encompass epidemiology and prevention of HIV/AIDS, research ethics, and humanitarian health, with particular focus on health and human rights, international relations, and ethical dilemmas involving vulnerable populations. His work spans multiple continents, with active research and mentoring in China, Lebanon, and Bhutan. Dr. Khoshnood's recent scholarly output demonstrates significant contributions to understanding healthcare delivery in conflict zones, with emphasis on Ukraine, Syria, and Yemen. His work combines epidemiological methods with human rights documentation, producing actionable evidence for humanitarian response. Through the Humanitarian Research Lab, he has pioneered methodologies for documenting war crimes against healthcare infrastructure and exposed Russia's program of coerced adoption of Ukrainian children. Among his notable recognitions are the Teacher of the Year Award from the Yale School of Public Health and the Surgeon General's Certificate of Appreciation. Dr. Khoshnood has served as a consultant for the Office of AIDS Research at the National Institute on Drug Abuse, extending his impact on national health policy. As Faculty Director of the Humanitarian Research Lab, Dr. Khoshnood oversees a team that analyzes open source and remote sensing data, including satellite imagery and social media information, to document humanitarian crises and support operational response. The Lab maintains rigorous chain-of-custody procedures for data preservation to support accountability mechanisms. Their real-time analyses provide critical support to partners delivering healthcare in conflict settings worldwide.

• Public Health
• Global Health
• HIV/AIDS Research
• +5 more

Orlando Stefano is an Assistant Professor at the Department of Hygiene and Public Health, University of Rome Tor Vergata. He specializes in global health, HIV/AIDS research, and epidemiology, with a focus on sub-Saharan Africa. His work includes studies on vaccine strategies, healthcare system transformation, and the impact of pandemics on healthcare delivery. He currently teaches courses on global health prevention and the evolving challenges in health systems. Research interests encompass maternal and child health, particularly in HIV-exposed infants, as well as aging populations and frailty assessment. He has contributed to initiatives like the DREAM program, addressing comorbidities in HIV patients and evaluating virological outcomes in Mozambique. His studies on gender dynamics in healthcare decision-making and the effects of public health measures on infection rates highlight his interdisciplinary approach. Key themes in his publications include vaccine efficacy in resource-limited settings, tuberculosis diagnosis during the pandemic, and the role of community-based care systems. His work frequently integrates clinical data with public health policy analysis, emphasizing actionable solutions for global health challenges. Stefano has advised on interventions to improve male partner involvement in maternal health programs in Malawi and has explored the economic impacts of healthcare resource allocation in sub-Saharan Africa. His research also addresses the socioeconomic implications of HIV treatment programs and the management of noncommunicable diseases in aging populations.

• Physiotherapy
• Dizziness
• Rehabilitation
• +4 more

Dr Joanna Long is a Lecturer in Physiotherapy at Queen Margaret University (QMU), part of the Division of Nursing, Biomedical Sciences, Pharmacy, Physiotherapy and Radiography (DNBSPPR). She joined QMU in 2021 and teaches on undergraduate and postgraduate Physiotherapy programs, focusing on respiratory care and developing entrepreneurial skills. Her clinical background includes roles in London, Glasgow, Edinburgh, and the Scottish Borders, with a specialization in dizziness and preventing hospital admissions via Emergency Department collaborations. She holds a PhD from the University of Edinburgh (2022), where her research explored point-of-care diagnostics for tuberculosis in low-resource settings, alongside entrepreneurship and healthcare innovation modules. Education: - BSc (Hons) Biomedical Science, University of Sheffield - PhD in point-of-care diagnostics, University of Edinburgh Research Interests: Rehabilitation, dizziness, global health equity, and belonging in healthcare. She employs both quantitative and qualitative research methods and is a full member of the Centre for Health, Activity and Rehabilitation Research at QMU. Affiliations: - Chartered Society of Physiotherapy - Health and Care Professions Council Teaching Highlights: - Leads respiratory physiotherapy education - Integrates entrepreneurship into healthcare training

• Computational Medicinal Chemistry
• Chemoinformatics
• Glycoscience
• +4 more

Robert J. Doerksen is Professor of Medicinal Chemistry in the Department of BioMolecular Sciences at the University of Mississippi School of Pharmacy , Associate Dean of the Graduate School , and Research Professor in the Research Institute of Pharmaceutical Sciences . Since 2004 he has combined computational chemistry with experimental collaborations to advance drug discovery, particularly in glycoscience and cannabinoid research. Education: B.S. (Double First Class Honours) in Mathematics & Physics, University of New Brunswick, 1986 Graduate Diploma in Christian Studies, Regent College, Vancouver, 1996 Ph.D. in Chemistry, University of New Brunswick, 1998 (Advisor: Prof. Ajit Thakkar) Postdoctoral Fellow, UC Berkeley (with Prof. Martin Head-Gordon) Postdoctoral Fellow, University of Pennsylvania (with Prof. Michael Klein) Research Interests: Dr. Doerksen’s laboratory develops and applies computational medicinal chemistry approaches spanning chemoinformatics , molecular dynamics , virtual screening , and machine learning to understand how small molecules interact with proteins. Central themes include: Glycoscience : lectin–glycan interactions, glycosyltransferase regulation, glycomimetic design. Cannabinoids : CB1/CB2 receptor allosteric modulation, cannabidiol pharmacology, synthetic cannabinoid SAR. Neglected & Infectious Diseases : malaria, hepatitis B, tuberculosis, SARS-CoV-2, urinary-tract infections. Drug Delivery & Formulation : nanoparticle coatings, pharmacokinetic optimization, bioavailability enhancement. Publications Trend: Over 2023–2025 his 15 most recent papers reveal intense activity at the intersection of AI-driven discovery , glycobiology , and cannabinoid pharmacology , with emphasis on anti-infective, anticancer, and CNS-active agents. Key contributions include first-in-class MraY inhibitors for TB, cannabinoid-inspired antivirals against SARS-CoV-2, and glycomimetic antagonists of bacterial adhesins for UTI prevention. Scientific Awards & Honors: UM School of Pharmacy Faculty Service Award (2015–2016) UM School of Pharmacy Faculty Service Award (2010–2011) Editorial Boards: Molecules , AIMS Biophysics , Pharmaceutical Sciences , Perspectives in Medicinal Chemistry Repeated NIH, DoD, NSF, Wellcome Trust, and international grant-review panels (2010–present) Guest Editor for multiple special issues in Molecules and Frontiers journals Advising & Mentoring: As Associate Dean, Dr. Doerksen oversees University-wide graduate programs, chairs the Graduate Recruiting Fellowship and Scholarship Committee, and mentors students across disciplines. Faculty advisor for the UM chapters of the Christian Pharmacists Fellowship International (since 2005) and Taiwanese Student Association (2022–2025). He actively participates in PhD and MS thesis committees worldwide and has delivered NSF GRFP information sessions to support trainee funding. Laboratories & Teams: He directs research within the Computational Chemistry and Bioinformatics Research CORE (CCBRC) , fostering collaborative projects involving medicinal chemists, structural biologists, pharmacologists, and data scientists. The group leverages high-performance computing resources at the University of Mississippi to perform large-scale virtual screening, AI/ML model development, and integrative structural biology studies.

• Tuberculosis Pathogenesis
• Mycobacterium tuberculosis
• Cell Wall Physiology
• +3 more

Christopher M. Sassetti is a Professor in the Department of Microbiology at the University of Massachusetts Chan Medical School (UMass Chan Medical School) and T.H. Chan School of Medicine. His research focuses on the pathogenesis of Mycobacterium tuberculosis, specifically understanding how the bacterium adapts to host environments, acquires nutrients, regulates its cell wall physiology, and survives antibiotic treatment. He completed his BS in Biology at Santa Clara University and his PhD in Immunology at the University of California, San Francisco. Dr. Sassetti leads the Sassetti Lab, which employs genetic, biochemical, and systems biology approaches to study tuberculosis. His work has identified critical metabolic pathways and survival mechanisms in M. tuberculosis, including cholesterol utilization and cell wall synthesis regulation. He holds additional academic roles in the Morningside Graduate School of Biomedical Sciences, including the Immunology and Microbiology Program, MD/PhD Program, and Postbaccalaureate Research Education Program. Recent research highlights include studies on host immune responses to tuberculosis, antibiotic efficacy under infection conditions, and the role of genetic interactions in pathogen survival. His lab has discovered that host fatty acid metabolism and autophagy pathways play key roles in restricting bacterial growth. Dr. Sassetti has been recognized as a Damon Runyon Foundation Scholar and has contributed to high-impact publications in Immunity , Science , and Cell . Current projects include understanding nutrient acquisition in vivo, phosphosignaling regulation of cell wall synthesis, and metabolic mechanisms driving antibiotic tolerance. Collaborative efforts with institutions like the Morningside Graduate School and global networks drive translational research toward novel tuberculosis therapies and vaccines.

• Public Health Ethics
• Global Health Ethics
• Infectious Diseases
• +5 more

Dr. Diego Silva is a Senior Lecturer in Bioethics at Sydney Health Ethics and the Sydney School of Public Health, University of Sydney. His work bridges public health ethics, political theory, and infectious disease management, with a focus on tuberculosis, antimicrobial resistance, and pandemic preparedness. He combines qualitative methods with conceptual analysis to address ethical challenges in health security. Education: BA & MA in Philosophy (University of Toronto), PhD in Public Health (University of Toronto) Research Interests Public Health Ethics Infectious Diseases Health Security Complexity and Systems Thinking Microbiome Research Recent Article Trends 2024 SSH Consortium grant on immuno-engineering infrastructure 2024-2026 CIHR-funded TB genomics project 2024 ZiF grant on territoriality ethics Peer-reviewed publications in journals like BMJ Global Health, Monash Bioethics Review, and PloS One Scientific Awards Mark S. Ehrenreich Prize (2016) Supervision Accepts higher-degree research students in Public Health Ethics, Global Health Ethics, and Health Policy Associations International Association of Bioethics International Union Against Tuberculosis and Lung Disease Dr. Silva teaches BETH5101 - Moral Theory and BETH5104 - Bioethics, Law, and Policy, while maintaining active collaborations with the World Health Organization and Public Health Agency of Canada.

Julia L. FinkelsteinView profile

Associate Professor

• Epidemiology and Nutrition
• One-carbon metabolism
• Maternal and child health
• +3 more

Julia L. Finkelstein, MS, MPH, ScD, is Associate Professor of Epidemiology and Nutrition in the Division of Nutritional Sciences at Cornell University’s College of Human Ecology and concurrently Associate Professor of Epidemiology in the Division of Epidemiology, Department of Population Health Sciences at Weill Cornell Medical College. She is the Follett Sesquicentennial Faculty Fellow , Director of the Maternal and Child Nutrition Program , and co-Director of the Joan Klein Jacobs Center for Precision Nutrition and Health , the Cochrane Center , and the WHO Collaborating Centre at Cornell. She also holds an adjunct Associate Professor appointment at St. John’s Research Institute, Bengaluru, India . Education Bachelor of Science – McGill University, Montréal, Canada Master of Public Health – Brown University, USA Master of Science – Harvard University (Epidemiology and Nutrition) Doctor of Science – Harvard University (Epidemiology and Nutrition) Research Focus Dr. Finkelstein is an epidemiologist whose laboratory centers on one-carbon metabolism and its role in women’s health across the lifespan—from preconception through pregnancy and postpartum. She designs and conducts large-scale randomized clinical trials, cohort studies, and surveillance programs in resource-limited settings in India, Sub-Saharan Africa, Latin America, and the United States . Her work integrates precision nutrition, mobile point-of-care diagnostics, and AI-driven analytics to improve maternal, neonatal, and child health outcomes. Scientific Awards & Honors NIH Technology Accelerator Challenge Prize – Innovative Global Health Diagnostics SUNY Chancellor Award for Scholarship & Creative Activities International Life Sciences Institute (ILSI) Award – Leadership in Nutrition Chair, Federation of American Societies for Experimental Biology (FASEB) One-Carbon Metabolism Research Interest Group (recently elected) Grants & Leadership Roles Dr. Finkelstein is Program Director of an NIH-funded training program on maternal and child nutrition and leads the Clinical Core of the NIH-funded PORTENT Center (Point-of-Care Diagnostics for Nutrition, Infection, and Cancer) within the NIH POCTRN network. She is a Global Public Voices Fellow (2021–22) through Cornell’s Einaudi Center, advocating for social and health equity in vulnerable populations. Laboratory & Teams The Finkelstein Laboratory at Cornell focuses on mechanistic and translational research in one-carbon metabolism, leveraging state-of-the-art biomarker assays, body-composition analyses, and microbiome profiling to develop and test precision nutrition interventions for women and children globally.

Fran AweekaView profile

Professor

• HIV Pharmacology
• Malaria Pharmacology
• Tuberculosis Pharmacology
• +6 more

Fran Aweeka is a Professor and Vice Chair of Research at the Department of Clinical Pharmacy, University of California San Francisco (UCSF) School of Pharmacy . She directs the Drug Research Unit (DRU) and serves as the Pharmacology Core Lead for the UCSF Center for AIDS Research . Her research focuses on pharmacokinetic and pharmacodynamic studies of HIV, malaria, and tuberculosis drugs, particularly in vulnerable populations in Africa and the U.S. She actively contributes to the PharmD degree program as a co-director of the Inquiry component and mentors students in pharmacology and international research. As a clinical pharmacologist with over 25 years of experience, Dr. Aweeka investigates drug interactions in co-infected patients, pharmacokinetics in pregnancy and pediatric populations, and mechanisms of HIV-associated inflammation. Her work includes PI roles on NIH R01 grants and leadership in global health initiatives like seasonal malaria chemoprevention studies in Uganda. The DRU under her direction provides advanced analytical techniques for drug quantification in plasma and target tissues, supporting over 30 NIH studies. Her recent research trends include pharmacokinetic-pharmacodynamic modeling of antimalarial and antiretroviral combinations, microvolume plasma assays , and drug exposure-response relationships in resource-limited settings. Publications from 2021–2025 reflect these areas, with emphasis on pregnancy pharmacokinetics , pediatric dosing , and global health pharmacology . Dr. Aweeka holds a PharmD from UCSF (1985) and a BS in Biological Sciences from USC (1981). She is a licensed pharmacist in California and has completed leadership programs like the Mentor Development Program . Her lab supports collaborative projects across national and international institutions, focusing on drug quantification in plasma, dried blood spots, and target cells.

• Tuberculosis
• Diagnostics
• Epidemiology
• +3 more

Madhukar Pai, MD, PhD is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) , based at the Montreal General Hospital site, and a Professor in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine and Health Sciences . He also holds an appointment in the Division of Respiratory Medicine, Department of Medicine, MUHC . He leads research within the Infectious Diseases and Immunity in Global Health Program and the Centre for Outcomes Research and Evaluation (CORE) . Education: MD – Medical degree (institution and year not specified in text) PhD – Doctoral degree (field and institution not specified in text) Research Interests: Professor Pai’s research revolves around tuberculosis (TB) , a disease causing 10 million new cases and 1.4 million deaths annually. His work integrates epidemiology , diagnostics evaluation , implementation science , and global health policy to accelerate TB control. A major strand involves rigorous evaluation of novel rapid molecular diagnostics compared to conventional tests, assessing accuracy, cost-effectiveness, and readiness for national policy adoption. He employs standardised (mystery) patients to measure quality of TB care in private and public sectors across India , South Africa , Indonesia , and Nigeria . The COVID-19 pandemic has added a new dimension, examining disruptions to TB services and leveraging lessons for resilient health systems. His overarching goal is translational epidemiology —ensuring that scientific advances rapidly translate into policies and practices that save lives. Publication Trends: Between 2022 and 2025, Professor Pai has published prolifically on TB diagnostics , care cascades , COVID-19 impacts , private sector engagement , antimicrobial resistance , and decolonizing global health . His articles frequently appear in The Lancet , BMJ Global Health , PLoS Medicine , and Nature Reviews Disease Primers , reflecting a commitment to high-impact, policy-relevant science. Methodological contributions include systematic reviews, meta-analyses, standardised patient studies, and qualitative policy analyses. Scientific Awards & Recognition: (No specific named awards detailed in the provided text) Funding & Grants: Professor Pai’s research is supported by competitive international grants focused on TB diagnostics implementation, health systems strengthening, and pandemic preparedness. While exact grant titles and amounts are not listed, his extensive publication record attests to sustained funding from agencies invested in global health research. Labs & Teams: He leads a multidisciplinary team within the Centre for Outcomes Research and Evaluation (CORE) and the Infectious Diseases and Immunity in Global Health Program at RI-MUHC. Collaborations span McGill University, the McGill International TB Centre, and numerous partners in high-burden countries.

• HIV/AIDS
• Cancer
• Implementation Science
• +5 more

Raul U. Hernandez-Ramirez is a Research Scientist in Biostatistics at the Center for Methods in Implementation and Prevention Science (CMIPS) at the Yale School of Public Health. He serves as Director of the Dissemination and Implementation Science Methods (DISM) Core at the Center for Interdisciplinary Research on AIDS (CIRA) and is an Affiliated Faculty member at the Yale Institute for Global Health. His work bridges biostatistics, implementation science, and global health research with a focus on practical applications for public health improvement. Dr. Hernandez-Ramirez earned his PhD in Public Health (Chronic Disease Epidemiology) from Yale University in 2018, following an MPhil in the same field in 2016. During his doctoral studies, he conducted research as a predoctoral visiting fellow at the National Cancer Institute (NCI). He further enhanced his expertise through specialized training programs including the Training Institute for Dissemination and Implementation Research in Cancer (TIDIRC) and the Multilevel Intervention Training Institute (MLTI) from NCI, as well as training in optimization of multicomponent interventions using the Multiphase Optimization Strategy (MOST). His research primarily focuses on HIV/AIDS, cancer, and implementation science. He develops and applies causal inference methods for evaluating HIV prevention interventions and methods to account for exposure uncertainty in environmental health studies. His work spans multiple settings including New Haven, other locations in the United States, and low- and middle-income countries, particularly Mexico. He is particularly interested in adapting and developing interventions to increase the uptake of evidence-based practices for HIV and cancer prevention and care, including follow-up care for abnormal cervical cancer screens. He is a member of the Yale Cancer Center (YCC) and the Yale Institute for Global Health (YIGH). Analysis of Dr. Hernandez-Ramirez's recent publications reveals a strong focus on gastric cancer epidemiology through the Stomach cancer Pooling (StoP) Project, examining dietary factors and their relationship to cancer risk. His work prominently features implementation science methodologies applied to HIV prevention and cancer screening programs, particularly in Mexican and other international settings. His research combines rigorous biostatistical methods with practical applications in global health contexts, with significant contributions to causal inference methods and network-randomized trial analysis. Provides expertise, consultations, and technical assistance on implementation science through CIRA's DISM core Contributes to projects in Ending the HIV Epidemic (EHE) priority areas through the CIRA-affiliated IS hub R3EDI Collaborates on research projects in New Haven, other US settings, and low- and middle-income countries including Mexico Offers seminars and trainings on research methods, design, and analysis to CIRA affiliates Dr. Hernandez-Ramirez previously gained substantial research experience in nutrition, environmental health, and cancer at the National Institute of Public Health of Mexico, where he worked as a researcher and instructor and served as project coordinator, data manager, and main statistician for a multistate study. He holds an MSc in Epidemiology and a BSc in Nutrition, establishing a strong foundation for his current work at the intersection of nutritional epidemiology and implementation science.

• Implementation Science
• Tuberculosis
• HIV
• +5 more

Luke Davis, MD is an Associate Professor of Epidemiology (Microbial Diseases) and Medicine (Pulmonary, Critical Care & Sleep Medicine) at Yale School of Public Health , with affiliated roles at Yale Institute for Global Health and Yale Medicine . He directs the Implementation Science Track and leads international research programs focused on tuberculosis (TB) and HIV. Education : MD (Vanderbilt University), AB (Princeton University), MAS in Clinical Research (University of California San Francisco), Fellowship in Pulmonary & Critical Care (UCSF) Clinical Practice : Attending physician at Yale-New Haven Hospital's Medical ICU and Winchester TB Clinic Research Focus : Implementation science strategies to improve TB and HIV diagnosis, treatment, and stigma reduction across Uganda, South Africa, Colombia, Mongolia, and the United States. Key projects include: Uganda : HIV-TB household contact investigations, gene-expression profiling for biomarker development, Xpert MTB Ultra evaluation Colombia : Cali TB contact investigation using design thinking Mongolia : Zero TB Initiative quality assessments Connecticut : COVID-19 contact tracing analysis Publication Trends (15 most recent): 50% focus on TB-HIV coinfection and implementation trials in Sub-Saharan Africa 30% on digital health technologies for infectious disease management 20% on geriatric care innovations and medical education Collaborations : Frequent co-authors include Sheela Shenoi , Salome Charalambous , and Donna Spiegelman . Research spans biomedical engineering integration, stigma reduction frameworks, and quality improvement methodologies.

• Drug Discovery
• Phase Change
• Peptide Assembly
• +7 more

Scott H. Medina is an Associate Professor in the Department of Biomedical Engineering at The Pennsylvania State University, with affiliations at the Penn State Cancer Institute, One Health Microbiome Center, and Cancer Institute's Next-Generation Therapies program. His research pioneers biomaterials and nanomedicine platforms for therapeutic and diagnostic applications. His expertise spans drug discovery, phase-changing nanomaterials, peptide assembly, antimicrobial/anticancer peptides, fluorous chemistry, and ultrasound-mediated therapies. He develops fluorine-modified biologics and peptide nanoemulsions to target cancer, infectious diseases, and neurodegenerative conditions, with research directly contributing to UN Sustainable Development Goals for health and well-being. Recent publications reveal dominant trends in ultrasound-programmable nanosystems: peptide nanoemulsions enable non-invasive biofilm debridement, atherosclerotic plaque detection, and amyloid β disruption, while metal-organic frameworks and fluorous protein coatings advance antibacterial and thermostable bioformulation strategies across cardiology, neurology, and infectious disease domains. Medina secures major funding from NIH (NIGMS, NCI, NIAID, NIDDK) and NSF, leading projects including cellular fate of fluorine-modified biologics (2021-2026), ultrasound contrast agents for cellular immunotherapies (2024-2025), biomimetic peptide aerosols for tuberculosis (2021-2024), and ultrasound-programmable kidney gene editing (2021-2023), plus an NSF CAREER award for phase-changing protein delivery systems (2019-2025). He directs a multidisciplinary laboratory collaborating with immunologists, infectious disease specialists, and cancer biologists to translate nanomedicine innovations into clinical applications for deep-tissue imaging, targeted drug delivery, and next-generation therapeutics.

• Public Health
• Internal Medicine
• Geriatrics
• +5 more

Muhammet Bayraktar serves as a Lecturer in the Department of Internal Medical Sciences and Department of Public Health at the Faculty of Medicine, Niğde Ömer Halisdemir University, where he has been employed since 2020 and previously served as Head of Department from 2020-2021. His academic credentials include: Doctorate in Public Health from Erciyes University (2013-2019), thesis: "Evaluation of the accuracy of information in death certificates in Niğde province" Licence in Medicine from Kahramanmaraş Sütçü İmam University (1999-2008) Dr. Bayraktar's research program demonstrates exceptional breadth across public health disciplines, with particular emphasis on geriatric care interventions, child protection systems, and pandemic response strategies. His innovative work on acupressure therapy for elderly patients represents a significant contribution to non-pharmacological approaches in geriatric medicine. His research consistently addresses practical public health challenges in the Turkish healthcare context through rigorous scientific methodology. Analysis of his publication record reveals a strategic evolution toward interdisciplinary research connecting clinical medicine with social determinants of health. Since 2020, his work has increasingly focused on pandemic-related challenges while maintaining his foundational research in hematology and child protection. His publications span high-impact journals across multiple specialties, demonstrating academic versatility and relevance to contemporary health challenges. Dr. Bayraktar has secured significant research funding including: "The Effect of Acupressure Applied to the Elderly on Constipation Symptoms and Quality of Life" (2021-2022), supported by Higher Education Institutions "Evaluation of the Effects of Acupressure on Neuropathic Symptoms, Balance Confidence, Fear of Falling, and Quality of Life in Elderly Individuals with Painful Diabetic Peripheral Neuropathy" (2025-), a TÜBİTAK 3501 project He has successfully supervised doctoral candidates including Tuğba Aydemir (research on acupressure for elderly constipation) and Rifat Güveli (research on nomophobia and mental health in adults), demonstrating commitment to the next generation of public health researchers.